Calumet Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $4.6B+9.6% YoYTTM through 30 Jun 2026
Net Income -$136.8MTTM through 30 Jun 2026
Free Cash Flow $73.5MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 6.6% |
| EBITDA Margin | 4.1% |
| Operating Margin | 1.0% |
| Net Margin | -3.0% |
Returns
4.6%ROE
-1.3%ROA
-14.0%ROIC
Balance Sheet Health
Debt / Equity-3.00x
Current Ratio1.02x
Net Debt$2.1B
Cash & Equivalents$109.8M
Quality Metrics
Altman Z-Score1.42
Piotroski F-Score6 / 9
FCF Margin1.6%
Rule of 408.6
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $4.1B
Diluted EPS-$1.54TTMFY2025: $-0.39
Dividend
No dividend
Capital Allocation
Capex Intensity1.6%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Specialty Products and Solutions | $2.6B | ||
| Montana/Renewables | $1.2B | View detailsMaxSAF 150 expansion on track for second quarter of 2026 to deliver 120 to 150 million gallons of annual SAF. | |
| Performance Brands | $311M |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.